They also restricted their analysis to studies reporting at least 3kg on-treatment average weight loss
Several medications are currently approved for the treatment of obesity
Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect
Glutamate excitotoxicity Anticancer drugs and some antibiotics elevate glutamate levels in the synaptic cleft between inner hair cells (IHCs) and auditory neurons, leading to overstimulation of N-methyl-D-aspartate (NMDA) receptors
Medical circumstances vary between individuals always seek advice from a qualified healthcare professional before making decisions about health, treatment, or participation in clinical research
Metabolic acidosis: This is caused by high acid levels in the blood with symptoms such as rapid breathing, fatigue, or heart rate changes
%20(1).png)
